DUBLIN--(BUSINESS WIRE)--The "Global Glycated Hemoglobin Testing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The analysts forecast the Global Glycated Hemoglobin Testing Market to grow at a CAGR of 9.13% during the period 2018-2022.
Glycated Hemoglobin Testing helps to determine the average blood glucose level of individuals two to three months prior to the test to understand whether diabetes is controlled.
One trend affecting this market is the increased adoption of automation in diabetes care. Fully automated solutions can save costs of staffing and generate precise results.
One driver influencing this market is the rising incidence of diabetes and related conditions. The growing prevalence of diabetes cater to the rise in the demand for diagnostic methods to detect diabetes.
The report states that one challenge affecting this market is the high cost of tests and reimbursement restrictions. Manufacturers may not be able to fully recover their expenses since most health insurance companies have limitations on reimbursements.
The market is divided into the following segments based on geography:
- Bio-Rad Laboratories
- EKF Diagnostics
- F. Hoffmann-La Roche
Key Topics Covered:
1: Executive Summary
2: Scope Of The Report
3: Research Methodology
4: Market Landscape
5: Market Sizing
6: Five Forces Analysis
7: Customer Landscape
8: Market Segmentation By End-User
9: Regional Landscape
10: Decision Framework
11: Drivers And Challenges
12: Market Trends
13: Vendor Landscape
14: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/gkj6zx/global_glycated?w=4